Neuroinflammation has been believed to be the key molecular event in the initial phase of AD; We next investigated how neuroinflammation and NADPH oxidase activation affected BaP’s aggravation of Aβ-induced AD progression. This evidence concerns the gene FMO5 and Alzheimer disease.